Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B

BACKGROUND AND AIM: Although tenofovir alafenamide (TAF), as well as entecavir (ETV), is widely used as first‐line treatment for patients with chronic hepatitis B, there are only a few studies comparing sequential therapy from ETV to TAF and continuous ETV monotherapy in patients with maintained vir...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:JGH Open
Główni autorzy: Itokawa, Norio, Atsukawa, Masanori, Tsubota, Akihito, Takaguchi, Koichi, Nakamuta, Makoto, Hiraoka, Atsushi, Kato, Keizo, Abe, Hiroshi, Mikami, Shigeru, Shimada, Noritomo, Chuma, Makoto, Akito, Nozaki, Uojima, Haruki, Ogawa, Chikara, Asano, Toru, Tani, Joji, Morishita, Asahiro, Senoh, Tomonori, Yamashita, Naoki, Oikawa, Tsunekazu, Matsumoto, Yoshihiro, Koeda, Mai, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Arai, Taeang, Hayama, Korenobu, Iwashita, Ai‐Nakagawa, Kondo, Chisa, Tada, Toshifumi, Toyoda, Hidenori, Kumada, Takashi, Iwakiri, Katsuhiko
Format: Artigo
Język:Inglês
Wydane: Wiley Publishing Asia Pty Ltd 2020
Hasła przedmiotowe:
Original Articles
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812481/
https://ncbi.nlm.nih.gov/pubmed/33490611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12443
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy